COMMUNIQUÉS West-GlobeNewswire

Idorsia announces financial results for the first nine months of 2024

29/10/2024 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – October 29, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first nine months of 2024. Highlights Net revenue 9M 2024 at CHF [...]

Novartis continues strong momentum in Q3 with 10% sales growth, 20% core operating income growth, and important innovation milestones; raises FY 2024 guidance

29/10/2024 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +10% (cc 1 , +9% USD) with core operating income up +20% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+26% cc), Cosentyx [...]

The world’s first 100% “fiber-to-fiber” biorecycled clothing unveiled by multi-brand consortium: CARBIOS, On, Patagonia, PUMA, PVH Corp. and Salomon

29/10/2024 - 06:45

For the first time, a piece of clothing is made entirely from textile waste – no bottles, no packaging, no virgin plastic. 100% biorecycled fibers. By developing and industrializing CARBIOS’ enzymatic depolymerization [...]

Le premier vêtement biorecyclé 100 % « fibre à fibre » du monde dévoilé par CARBIOS, On, Patagonia, PUMA, PVH Corp. et Salomon

29/10/2024 - 06:45

Pour la première fois, un vêtement a été entièrement confectionné à partir de déchets textiles : pas de bouteilles, pas d’emballages, pas de plastique vierge. Uniquement 100 % de fibres recyclées. En développant et en [...]

Gelteq Limited Prices US$5.2 Million Initial Public Offering

29/10/2024 - 02:50

Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS” NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology [...]

Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock

29/10/2024 - 02:15

WILMETTE, Ill., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments [...]

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

29/10/2024 - 00:02

Raanana, Israel, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or "PLRZ"), a development stage biotech company specializing in the development of innovative medical device hydrogels, today announced [...]

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

28/10/2024 - 22:37

BRISBANE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with [...]

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

28/10/2024 - 22:14

WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]

NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November

28/10/2024 - 21:30

NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

28/10/2024 - 21:19

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing [...]

Certara to Participate in the Stephens Annual Investment Conference

28/10/2024 - 21:15

RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the Stephens Annual Investment [...]

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

28/10/2024 - 21:10

CARSON CITY, Nev., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]

Inari Medical Reports Third Quarter 2024 Financial Results

28/10/2024 - 21:05

IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

28/10/2024 - 21:05

GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting

28/10/2024 - 21:05

Ninety percent of survey participants reported “some” or “significant” negative impact of IBS-C on their life Survey results presented in two poster presentations WALTHAM, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- [...]

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

28/10/2024 - 21:01

WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]

Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock

28/10/2024 - 21:00

WILMETTE, Ill., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments [...]

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

28/10/2024 - 20:13

CARSON CITY, Nev., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]